GBT Global Blood Therapeutics Inc

Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.

$43.95  -0.53 (-1.19%)
As of 03/02/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
08/12/2015
62,156,860
1,007,935
$2,764,737,133
0.00%
SEC Edgar Online
10-Q
10-K
37890U108
US37890U1088
BZ05388

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.15
6.61
22.33
-59.49%
-199.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy